Vaccination With Autologous Dendritic Cells Pulsed With Tumor Lysate for Treatment of Patients With Malignant Pleural Mesothelioma.

Trial Profile

Vaccination With Autologous Dendritic Cells Pulsed With Tumor Lysate for Treatment of Patients With Malignant Pleural Mesothelioma.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 May 2016

At a glance

  • Drugs Dendritic cell vaccine-Amphera (Primary)
  • Indications Mesothelioma
  • Focus Adverse reactions
  • Acronyms DC-immunotherapy
  • Most Recent Events

    • 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Aug 2009 Planned end date changed from 31 Dec 2008 to 1 Dec 2009 as reported by ClinicalTrials.gov.
    • 25 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top